hepat
b
viru
hbv
uniqu
tini
partial
doublestrand
reversetranscrib
dna
viru
protein
encod
multipl
overlap
read
frame
substitut
rate
surprisingli
high
dna
viru
lower
revers
transcrib
organ
million
peopl
worldwid
chronic
hbv
infect
caus
million
death
year
high
burden
diseas
intern
health
agenc
set
goal
elimin
hbv
infect
nonetheless
intrigu
hbv
genom
well
character
summar
data
hbv
genom
structur
replic
cycl
explain
quantifi
divers
within
among
infect
individu
discuss
advanc
offer
applic
nextgener
sequenc
technolog
indepth
hbv
genom
analys
could
increas
understand
diseas
pathogenesi
allow
us
better
predict
patient
outcom
optim
treatment
develop
new
therapeut
insight
deep
sequenc
hbv
genomeuniqu
tini
misunderstood
h
epat
b
viru
hbv
first
identifi
baruch
blumberg
went
win
nobel
prize
discoveri
viru
lead
caus
liver
diseas
worldwid
estim
million
individu
chronic
infect
approxim
one
third
world
popul
serolog
evid
exposur
hbv
global
public
health
problem
endem
level
infect
southeast
asia
africa
preval
rate
least
mani
popul
howev
hbv
underrepres
term
resourc
alloc
polit
advocaci
research
chronic
hbv
infect
lead
liver
inflamm
longterm
risk
cirrhosi
hepatocellular
carcinoma
hcc
contrast
decreas
mortal
human
immunodefici
viru
hiv
tuberculosi
malaria
hbvassoci
mortal
increas
unit
nation
sustain
develop
goal
set
challeng
elimin
hbv
infect
public
health
threat
howev
substanti
barrier
elimin
includ
gap
vaccin
coverag
long
period
vaccin
effect
popul
preval
lack
cure
challeng
includ
viru
resist
drug
lesser
extent
vaccin
hiv
coinfect
stigma
poverti
lack
educ
limit
access
diagnost
test
hbv
infect
treat
interferon
nucleo
ide
analogu
revers
transcriptas
rt
inhibitorsprimarili
tenofovir
entecavirwhich
limit
liver
damag
suppress
viral
replic
howev
interferon
therapi
associ
unpleas
side
effect
cure
small
percentag
patient
nucleo
ide
analogu
rt
inhibitor
decreas
viremia
consist
effect
clearanc
therefor
rebound
viremia
cessat
common
great
need
cure
hbv
infect
achiev
elimin
target
cur
therapi
hbv
import
goal
individu
patient
intern
public
health
agenda
cure
hbv
infect
requir
detail
robust
understand
genet
sequenc
structur
divers
hbv
scientif
invest
requir
develop
dataset
supplement
hepadnaviru
isol
chimpanze
orangutan
gorilla
wide
cite
hbv
genotyp
strain
b
midpointroot
maximum
likelihood
phylogenet
tree
gener
use
bootstrap
replic
use
indic
relat
hbv
genotyp
subtyp
typic
geograph
distribut
wide
use
refer
sequenc
genotyp
ad
f
includ
genotyp
singl
subtyp
refer
sequenc
use
gener
tree
sequenc
use
gener
tree
genotyp
panel
divers
infecti
clone
replic
cell
line
anim
support
drug
resistancescreen
program
detail
insight
immun
control
clearanc
gain
identifi
site
immun
select
pressur
viru
genom
approach
help
identifi
immun
correl
hiv
control
past
decad
increas
understand
viru
genet
improv
manag
patientsin
stratif
select
therapi
identif
drugand
vaccineresist
strain
develop
new
approach
monitor
hbv
sequenc
data
larg
consist
consensu
sequenc
individu
viral
gene
deriv
sanger
sequenc
howev
nextgener
sequenc
ng
platform
rapidli
becom
access
afford
addit
new
bioinformat
approach
handl
result
dataset
addit
enabl
wholegenom
sequenc
ng
offer
power
method
detect
minor
variant
relev
identif
drug
resist
studi
quasispeci
dynam
character
complex
viral
popul
togeth
improv
curat
public
clinic
metadata
accur
fulllength
ultradeep
hbv
sequenc
data
provid
increas
opportun
develop
new
insight
hbv
evolut
divers
pathogenesi
immun
control
treatment
outcom
provid
solid
foundat
interpret
new
sequenc
dataset
assimil
avail
data
hbv
genom
structur
function
divers
summar
gain
made
use
ng
platform
hbv
prototyp
viru
hepadnavirida
familysmal
spheric
virus
icosahedr
symmetri
combin
partial
doublestrand
ds
dna
genom
virusencod
rt
within
baltimor
viru
classif
system
classifi
virus
base
genom
composit
replic
cycl
hepadnavirida
classifi
group
vii
sometim
refer
pararetrovirus
anim
virus
group
recent
famili
divid
genera
orthohepadnaviru
speci
infect
mammal
includ
primat
bat
avihepadnaviru
speci
infect
bird
howev
recent
discoveri
put
hepadnavirus
infect
fish
amphibian
indic
viral
famili
might
larger
initi
believ
figur
base
sequenc
divers
hbv
divid
genotyp
put
genotyp
figur
hepadnavirus
smallest
known
viral
genom
rang
kb
hbv
genom
approxim
kb
figur
circular
partial
doubl
strand
hbv
genom
encod
genespolymeras
p
surfac
precorecor
c
x
protein
encod
discret
open
read
frame
orf
figur
hbv
produc
viral
rna
transcript
vari
length
translat
distinct
protein
figur
b
basic
genom
organ
common
hepadnavirus
although
x
gene
absent
avihepadnaviru
speci
except
vestigi
x
gene
duck
hepadnavirus
compact
natur
hepadnaviru
genom
multipl
overlap
read
frame
result
approxim
two
third
nucleotid
encod
function
element
genom
structur
encompass
viru
gene
regulatori
region
restrict
redund
within
code
region
figur
annot
hbv
genom
replic
cycl
overlap
orf
product
encod
gene
product
indic
text
box
start
end
posit
deriv
use
refer
strain
major
function
domain
p
gene
product
indic
dot
line
larg
hb
consist
medium
hb
consist
small
hb
consist
overlap
nucleotid
p
gene
largest
gene
overlap
known
anim
viru
nearcomplet
neg
dna
strand
partial
complet
posit
dna
strand
dot
line
indic
approxim
miss
region
also
shown
addit
posit
end
complet
negativesens
dna
strand
coval
bound
viral
rt
complementari
positivesens
dna
strand
partial
complet
cover
approxim
two
third
viral
genom
end
incomplet
strand
defin
short
oligoribonucleotid
region
end
vari
within
among
host
b
replic
cycl
adapt
liang
special
issu
infect
hbv
virion
serum
often
refer
dane
particl
diamet
nm
capsid
structur
icosahedr
symmetri
nm
popul
nm
popul
ii
viru
enter
hepatocyt
hspg
lowaffin
bind
solut
carrier
famili
member
also
call
sodium
taurochol
cotransport
polypeptid
ntcp
highaffin
bind
iii
molecular
process
uncoat
nuclear
import
unclear
like
requir
cell
protein
iv
viral
dna
enter
nucleu
rcdna
v
viral
dna
reconfigur
cccdna
within
nucleu
cell
dna
repair
factor
stabl
structur
occur
associ
host
histon
mediat
dna
packag
vi
open
cccdna
structur
templat
host
rna
polymeras
ii
vii
dna
transcrib
pregenom
rna
intermedi
nucleu
creat
mrna
blue
transcript
encod
precor
rna
fulllength
pregenom
rna
also
shown
green
mrna
transcript
pre
respect
mrna
encod
x
protein
rna
transport
cytoplasm
translat
viral
protein
short
medium
long
protein
core
e
antigen
polymeras
x
protein
viii
hbv
rt
produc
negativestrand
dna
pregenom
rna
rna
templat
degrad
rnase
h
synthesi
positivestrand
dna
initi
hbv
dna
repackag
relax
form
protein
insid
host
cell
ix
new
virion
viral
protein
releas
blood
excess
hbsag
form
small
noninfecti
subvir
particl
nm
diamet
long
filament
free
hbeag
capsid
also
secret
c
core
hbeag
hepat
b
e
antigen
hbx
hepat
b
x
protein
hspg
heparan
sulfat
proteoglycan
nctp
na
taurochol
cotransport
polypeptid
pol
polymeras
tp
termin
protein
figur
one
specif
exampl
ntermin
region
precor
protein
highli
conserv
among
orthohepadnaviru
speci
like
owe
constraint
overlap
encapsid
signal
epsilon
sequenc
negativesens
genom
dna
strand
complementari
mrna
transcript
complet
strandit
held
circular
conform
overlap
end
genom
rang
bp
avihepadnaviru
speci
bp
orthohepadnaviru
speci
partial
doubl
strand
relax
circular
rcdna
hbv
virion
convert
coval
close
circular
dna
cccdna
insid
hepatocyt
nucleu
viral
polymeras
fill
partial
singlestrand
region
genom
figur
biogenesi
cccdna
includ
exact
mechan
dna
repair
partial
singlestrand
dna
region
rcdna
fulli
understood
like
cell
enzym
tyrosyldna
phosphodiesteras
contribut
cccdna
format
cleavag
hbv
p
rcdna
viral
cccdna
extrem
stabl
persist
nucleu
viral
minichromosom
lifespan
cell
provid
transcript
templat
rna
speci
translat
viral
protein
figur
addit
persist
minichromosom
form
cccdna
hepadnaviru
dna
also
integr
host
genom
woodchuck
integr
usual
occur
within
myc
protooncogen
eventu
caus
hcc
almost
infect
anim
human
hbv
integr
occur
differ
site
within
genom
consequ
less
clear
although
chronic
hbv
infect
associ
liver
cancer
integr
hbv
dna
host
genom
gene
typic
remain
control
nativ
promot
leav
integr
genom
sourc
hbv
surfac
antigen
hbsag
product
infect
infecti
viral
particl
contain
hbv
genom
secret
infect
hepatocyt
addit
smaller
subvir
particl
long
tubular
filament
particl
particl
empti
shell
form
hbsagthey
lack
capsid
viru
genom
therefor
noninfecti
particl
typic
outnumb
infecti
virion
much
believ
involv
immun
evas
bind
neutral
antibodi
potenti
promot
tcell
anergi
similar
particl
document
woodchuck
hbv
model
indic
common
role
orthohepadnaviru
infect
nine
differ
hbv
genotyp
ai
defin
diverg
nucleotid
level
put
genotyp
j
character
isol
individu
hbv
genotyp
divid
least
subtyp
diverg
wide
variat
observ
number
subtyp
describ
per
genotyp
tabl
substanti
differ
among
genotyp
geograph
distribut
transmiss
mode
clinic
outcom
includ
emerg
drug
resist
respons
therapi
tabl
howev
data
incompleteparticularli
lowand
middleincom
countri
furthermor
difficult
associ
differ
diseas
progress
outcom
hbv
genet
sequenc
vs
popul
behavior
coinfect
exposur
drug
hepatotoxin
human
genet
factor
studi
focus
small
number
individu
rel
restrict
area
prospect
highresolut
genomewid
associ
studi
larg
number
patient
requir
determin
interact
human
viru
genom
affect
outcom
sequenc
data
indic
wide
variat
number
subtyp
within
genotyp
rang
genotyp
c
distinct
subtyp
genotyp
e
g
h
j
consist
singl
subtyp
figur
molecular
clock
analysi
indic
genotyp
c
like
oldest
genotyp
larg
number
subtyp
keep
protract
endem
associ
human
popul
howev
challeng
studi
evolut
hbv
lack
tempor
structur
confound
molecular
clock
analys
genotyp
f
h
smaller
number
subtyp
highli
diverg
genotyp
might
higher
rate
substitut
genotyp
f
higher
intersubtyp
divers
genotyp
could
due
geograph
rang
popul
infectsfrom
nativ
alaskan
latin
american
popul
genotyp
b
c
associ
higher
rate
vertic
transmiss
genotyp
genotyp
c
f
associ
earlier
progress
hcc
particularli
alaskan
nativ
routin
genotyp
analysi
hbv
infect
individu
clinic
practic
recommend
us
asiapacif
european
clinic
guidelin
larg
result
affect
treatment
decis
howev
recent
european
us
guidelin
recogn
genotyp
variat
associ
respons
therapi
pegyl
interferon
alfa
treatment
recommend
patient
neg
hbv
e
antigen
hbeag
infect
genotyp
e
differ
stop
point
propos
patient
infect
genotyp
ad
respond
therapi
new
therapi
develop
genotyp
subtyp
data
becom
wide
avail
develop
better
understand
effect
genotyp
treatment
outcom
robust
molecular
biolog
compar
bioinformat
studi
divers
hbv
strain
publish
sequenc
hbv
genotyp
b
c
togeth
account
publish
fulllength
genom
data
download
august
univers
accept
refer
sequenc
number
amino
acid
residu
provid
import
foundat
unifi
research
effort
mind
use
previous
publish
hbv
protein
align
point
refer
pinpoint
site
immun
epitop
within
hbv
genom
consist
number
hbv
genom
challeng
genotypespecif
differ
genom
length
circular
genom
unifi
system
would
valuabl
similar
propos
hcv
number
base
refer
strain
consist
approach
propos
document
insert
delet
convent
hbv
number
base
molecular
clone
genom
typic
use
genotyp
genotyp
refer
strain
defin
genom
origin
ecori
restrict
site
gaatcc
nucleotid
start
embed
within
overlap
p
gene
presenc
restrict
site
hypothet
mani
hbv
isol
number
convent
alway
follow
sequenc
data
must
examin
realign
ensur
consist
number
sever
central
databas
hbv
sequenc
includ
hbvdb
hepseq
http
wwwhepseqorg
publicwebfrontmainphp
recent
studi
report
refer
sequenc
subtyp
genotyp
c
howev
unifi
set
refer
sequenc
hbv
genotyp
subtyp
differ
hcv
hiv
larg
sequenc
databas
consist
use
refer
sequenc
support
resourc
hbv
field
work
progress
toward
develop
unbias
method
wholegenom
sequenc
number
sequenc
deposit
databas
like
increas
consider
curat
align
valid
genotyp
subtyp
refer
sequenc
would
valuabl
resourc
research
ensur
compar
analys
conduct
base
consist
approach
intergenotyp
hbv
recombin
report
situat
rang
individu
case
report
mutat
introduc
prematur
stop
codon
precor
result
loss
hbeag
express
c
basal
core
promot
mutat
result
decreas
hbeag
express
sequenc
genotyp
character
although
genet
distanc
isol
suggest
might
subtyp
recombin
reach
fixat
meet
criteria
classif
separ
genotyp
genotyp
subtyp
breakpoint
recombin
randomli
distribut
throughout
genotyp
base
ecori
number
convent
breakag
tend
occur
site
within
nucleotid
possibl
decreas
betweengenotyp
divers
observ
region
addit
genotyp
recombin
exampl
includ
b
c
recombin
part
mainland
east
asia
defin
subgenotyp
c
recombin
report
tibet
china
e
recombin
report
differ
part
africa
c
g
recombin
report
patient
chinaalthough
base
sequenc
stretch
genom
g
recombin
sequenc
identifi
patient
infect
sever
patient
canada
intragenotyp
hbv
recombin
also
describ
genotyp
b
c
e
increas
frequenc
intragenotyp
recombin
strain
compar
genotyp
genotyp
b
c
like
reflect
long
associ
human
welldefin
subtyp
refer
strain
could
use
identifi
recombin
event
explain
current
distribut
divers
viral
variant
predict
futur
evolutionari
direct
epidem
deep
sequenc
analys
increas
understand
hbv
divers
evolut
control
immun
respons
resist
treatment
dispar
clinic
outcom
success
secondgener
shortread
sequenc
synthesi
approach
ng
studi
potenti
increas
understand
viral
divers
exampl
studi
detect
minor
variant
popul
low
level
associ
quasispeci
divers
treatment
outcom
hbeag
statu
sever
factor
hamper
understand
natur
effect
intrahost
divers
hbv
studi
use
wholegenom
sequenc
analys
sequenc
output
bias
need
prior
dna
amplif
especi
viral
load
low
represent
rcdna
reservoir
rather
cccdna
sequenc
studi
hcv
found
divers
differ
region
genom
indic
contrast
biolog
process
region
world
hbv
endem
mix
infect
common
challeng
differenti
coinfect
true
recombin
use
current
sequenc
approach
sever
ng
platform
includ
illumina
roch
reli
short
read
ampliconbas
approach
respect
therefor
fullgenom
reconstruct
individu
quasispeci
difficult
infer
multipl
genotyp
detect
unclear
develop
new
longread
sequenc
technolog
oxford
nanopor
technolog
pacif
bioscienc
menlo
park
ca
enabl
accur
haplotyp
reconstruct
increas
specif
recombin
strain
distinguish
mix
infect
uniqu
combin
dna
genom
coupl
multipl
overlap
orf
rt
step
stabl
cccdna
reservoir
lead
complex
uniqu
replic
process
one
hand
evid
hbv
rel
low
mutat
rate
substitut
per
site
per
year
compar
rt
virusesfor
exampl
rate
mutat
less
hiv
substitut
per
site
per
year
figur
hand
hbv
divers
dsdna
virus
figur
level
variat
rate
evolut
compar
rna
viru
dna
viru
unusu
replic
cycl
genom
structur
make
difficult
estim
genomewid
rate
viru
evolut
consider
variat
rate
hbv
evolut
faster
rate
evolut
observ
individu
chronic
infect
specif
time
period
analys
famili
greater
divers
observ
hbeagneg
infect
longterm
rate
hbv
evolut
lower
rate
report
shortterm
studi
exampl
sequenc
hbv
figur
hbv
divers
relat
genom
type
substitut
rate
estim
evolutionari
rate
substitut
per
nucleotid
per
year
taken
calcul
use
bayesian
molecular
clock
approach
differ
genom
type
median
rate
evolut
interquartil
rang
iqr
dsdna
iqr
dsrna
iqr
iqr
iqr
ssdna
b
distribut
divers
along
hbv
genom
fulllength
hbv
genom
sequenc
obtain
hbvdb
august
n
sequenc
align
use
mafft
http
mafftcbrcjpalignmentserv
sequenc
genotyp
randomli
shuffl
use
function
within
sse
sequenc
genotyp
randomli
select
analysi
normal
number
sequenc
genotyp
analyz
sequenc
avail
genotyp
f
genotyp
g
h
j
exclud
analysi
insuffici
number
sequenc
avail
comparison
genotyp
withingenotyp
pairwis
nucleotid
distanc
calcul
genotyp
af
use
sse
use
window
size
bp
increment
bp
greatest
variabl
typic
sequenc
diverg
observ
region
overlap
orf
entropi
nucleotid
within
dataset
calcul
use
sse
c
comparison
shannon
entropi
site
overlap
nonoverlap
region
hbv
genom
genotyp
analyz
individu
region
genom
divid
overlap
nonoverlap
region
use
annot
genom
http
hbvdbibcpfrhbvdbhbvdbgenom
mean
shannon
entropi
overlap
region
significantli
lower
confid
interv
nonoverlap
region
confid
interv
p
mannwhitney
utest
c
core
dsrna
doublestrand
rna
hcv
hepat
c
viru
ssdna
singlestrand
dna
ssrna
singlestrand
rna
isol
set
mummifi
remain
korea
itali
minim
genet
diverg
modern
hbv
sequenc
overlap
orf
offer
fit
advantag
virus
high
rate
mutat
substitut
region
higher
odd
produc
detriment
effect
addit
evid
mani
substitut
occur
viral
genom
cours
chronic
infect
might
gener
variat
revers
back
genotyp
consensu
therefor
substitut
hbv
genom
maintain
long
term
rate
substitut
overlap
region
hbv
genom
lower
nonoverlap
region
figur
signific
differ
entropi
region
figur
overlap
regulatori
element
encod
rna
secondari
structur
requir
replic
orf
provid
constraint
nucleotid
substitut
hbv
genom
exampl
divers
within
genotyp
nonoverlap
region
within
x
gene
decreas
rel
nonoverlap
region
figur
like
result
overlap
basal
core
promot
region
regulatori
element
genom
control
express
precor
mrna
pregenom
rna
mani
hbv
genotyp
unexpectedli
high
level
divers
start
gene
although
region
overlap
p
gene
intriguingli
diverg
region
ps
overlap
often
refer
spacer
region
pol
pattern
codon
use
distinct
two
third
overlap
propos
p
sequenc
region
ps
overlap
evolv
independ
mutat
delet
region
greatli
affect
function
encod
polymeras
region
correspond
hydrophil
region
strong
immun
pressur
overlap
gene
indic
spacer
region
p
allow
conform
adapt
select
pressur
analysi
hbv
sequenc
famili
transmiss
network
found
precor
middl
region
gene
hotspot
sequenc
divers
compar
rel
overlap
orf
regulatori
region
viral
genom
figur
impos
constraint
viral
plastic
nonsynonym
mutat
accommod
within
differ
protein
viabl
make
mutat
disadvantag
exampl
constrain
evolut
highlight
greater
divers
nonoverlap
region
figur
c
exampl
includ
highli
conserv
epsilon
sequenc
overlap
uniqu
nterminu
precor
gene
nucleotid
substitut
posit
constrain
select
precor
start
codon
mutat
oppos
strand
redund
within
third
codon
posit
region
orf
overlap
allow
select
mutat
figur
host
immun
respons
select
escap
mutat
eg
within
flank
tcell
epitop
exposur
antivir
therapi
select
drug
resist
mutat
select
precor
stop
codon
bcp
mutat
superior
transmiss
potenti
wildtyp
variant
transmiss
bottleneck
limit
divers
onset
new
infect
long
durat
infect
gener
divers
quasispeci
popul
within
host
replic
cycl
stabl
reservoir
cccdna
long
halflif
figur
estim
cccdna
halflif
duck
hepadnavirus
human
averag
cccdna
halflif
estim
mo
differ
markedli
hbeagposit
mo
hbeagneg
mo
individu
studi
need
determin
halflif
human
differ
stage
diseas
progress
errorpron
viral
rt
enzym
high
substitut
rate
transcrib
pgrna
rcdna
figur
hbv
produc
high
rate
replic
genotyp
lowest
level
divers
observ
genotyp
e
figur
singl
report
subtyp
increas
divers
featur
specif
genotyp
genotyp
f
diverg
consider
genotyp
show
high
level
intersubtyp
divers
figur
adapt
genet
divers
popul
point
evolutionari
histori
could
explain
increas
substitut
rate
bcp
basal
core
promot
hbeag
hepat
b
e
antigen
conserv
region
genotyp
oppos
effect
hbv
genet
divers
present
tabl
determin
genotyp
baselin
test
drug
resist
rare
perform
preval
mutat
hbv
caus
resist
treatment
vari
worldwid
unit
state
canada
african
cohort
data
need
area
mani
individu
also
hiv
infect
mani
patient
expos
antiretrovir
therapi
includ
nucleo
ide
analogu
lamivudin
tenofovir
prior
exposur
antiretrovir
therapi
could
increas
risk
mutat
hbv
mediat
resist
treatmentparticularli
lamivudin
low
barrier
resist
although
strain
hbv
resist
tenofovir
describ
unusu
effect
patient
outcom
clear
therefor
tenofovir
often
recommend
nonrespons
altern
therapi
although
region
hbv
genom
highli
conserv
data
intrapati
divers
simultan
compet
evolutionari
pressur
creat
differ
subpopul
hbv
within
patient
quasispeci
popul
level
produc
divers
rcdna
popul
less
divers
stabl
cccdna
popul
differ
sequenc
polymorph
potenti
archiv
cccdna
pool
figur
stabli
fix
viru
popul
mutant
genom
egress
virion
must
effect
compet
circul
wildtyp
virus
infect
hepatocyt
gener
cccdna
uniqu
popul
structur
maxim
potenti
pool
mutant
enabl
advantag
viru
adapt
within
patient
still
elimin
virus
deleteri
mutat
lessfit
rcdna
genom
might
persist
bypass
egress
recycl
directli
back
nucleu
replenish
viral
cccdna
popul
howev
model
base
observ
duck
hepadnaviru
clearli
document
human
hbv
infect
certain
hbv
polymorph
delet
associ
specif
clinic
outcom
cirrhosi
hcc
exampl
includ
divers
pre
region
correl
progress
chronic
hbv
infect
hcc
howev
delet
pre
region
associ
hcc
patient
infect
hbv
genotyp
b
c
particular
pre
delet
nt
hbv
genotyp
c
larg
delet
result
splice
hbv
pregenom
rna
associ
advanc
liver
diseas
includ
cirrhosi
hcc
mutat
basal
core
promot
detect
pyrosequenc
associ
increas
risk
diseas
progress
cirrhosi
hcc
popul
mostli
patient
hbv
genotyp
b
c
infectionindepend
viral
load
likewis
viral
divers
like
affect
respons
treatment
although
relat
clearli
defin
larg
studi
correl
higher
level
viru
divers
particularli
basal
core
promot
precor
region
lower
probabl
hbsag
loss
studi
associ
hbv
heterogen
posit
effect
treatment
wide
rang
measur
use
assess
divers
hbv
infect
individu
broad
estim
viru
divers
made
use
pairwis
entropybas
measur
detect
minor
variant
viral
popul
specif
polymorph
often
associ
drug
resist
detect
mixedgenotyp
subtyp
infect
import
increas
understand
quasispeci
dynam
better
understand
select
fixat
polymorph
affect
patient
outcom
includ
viru
resist
drug
vaccin
antiviru
immun
respons
develop
chronic
liver
diseas
divers
viru
popul
could
aris
immun
select
pressur
balanc
benefit
immuneescap
mutat
deleteri
effect
mutat
hbv
fit
replic
capac
studi
motherchild
pair
demonstr
rel
tight
bottleneck
transmiss
limit
viru
divers
infect
children
compar
motherssuggest
proport
hbv
strain
mother
transfer
child
mother
hbv
hiv
coinfect
minor
hbv
variant
may
establish
domin
viru
infant
mutat
hbsag
frequent
observ
strain
indic
hiv
infect
open
hbv
transmiss
bottleneck
analys
intrahepat
quasispeci
demonstr
associ
intrahepat
divers
focus
within
tcell
epitop
offtreat
control
indic
role
immunemedi
select
pressur
control
viremia
similarli
increas
divers
quasispeci
associ
effect
therapi
although
observ
consist
bloodborn
viru
infect
intrapati
viru
divers
associ
strong
suppress
treatment
convers
poor
patient
outcom
howev
studi
factor
affect
divers
hbv
confound
factor
genotyp
subtyp
small
heterolog
cohort
variat
sequenc
method
examin
differ
area
genom
therefor
challeng
uncov
true
associ
studi
also
confound
geograph
distribut
genotyp
ethnic
affect
individu
chronic
hbv
infect
fundament
global
public
health
challeng
centuri
enough
unbias
gener
interpret
sequenc
data
attempt
unifi
data
relev
resourc
genom
annot
refer
sequenc
robust
link
clinic
data
develop
unbias
metagenom
pipelin
alongsid
care
collat
host
metadata
begun
affect
manag
patient
infecti
diseas
although
deep
sequenc
approach
robustli
appli
hbv
sever
situat
ng
data
could
substanti
valu
develop
diagnost
tool
select
treatment
analys
transmiss
studi
hbv
pathogenesi
viru
diagnost
ng
could
use
identifi
known
novel
virus
exclud
infecti
etiolog
clinic
syndrom
previous
unrecogn
hbv
coinfect
detect
use
metagenom
approach
cohort
patient
acut
liver
failur
new
splice
variant
identifi
use
pacif
bioscienc
technolog
time
ng
might
use
identifi
exist
new
drugresist
mutat
studi
dynam
strategi
develop
bring
genom
sequenc
analysi
clinic
virolog
laboratori
exampl
pre
delet
pattern
combin
quantit
ng
data
machin
learn
method
might
use
identifi
patient
risk
liver
diseas
progress
ng
also
might
use
character
vertic
transmiss
bottleneck
identifi
track
outbreak
rang
set
challeng
remain
widespread
applic
ng
platform
includ
need
deplet
host
read
could
requir
enrich
amplif
step
particularli
detect
virus
low
copi
number
system
reagent
expens
interpret
ng
data
requir
consider
bioinformat
support
adapt
differ
genom
configur
hbv
mean
refin
method
circular
partial
dsdna
genom
howev
develop
portabl
realtim
thirdgener
sequenc
platform
nanopor
minion
oxford
nanopor
technolog
made
prospect
deep
sequenc
point
care
test
increasingli
feasibl
rel
short
simpl
sampl
prepar
protocol
minim
setup
requir
laptop
comput
low
cost
rel
convent
benchtop
sequenc
make
technolog
particularli
appeal
resourcelimit
set
although
error
rate
nanopor
high
robust
applic
studi
pathogen
divers
rapid
improv
made
laboratori
bioinformat
protocol
substanti
gap
remain
understand
relationship
hbv
genom
structur
replic
cycl
divers
transmiss
clinic
outcom
recent
sequenc
advanc
offer
enorm
opportun
gener
dataset
help
address
question
gener
standard
refer
genom
hbv
genotyp
subtyp
enabl
robust
consist
collat
analysi
requir
develop
insight
current
futur
epidemiolog
inform
better
clinic
assess
prognost
improv
deploy
current
antivir
drug
vaccin
drive
discoveri
new
therapeut
agent
